Cantuzumab mertansine

Cat. No.: IBDI-431740

Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts.

Product Details

Target	Antibody-Drug Conjugates (ADCs) | Microtubule/Tubulin
Synonyms	SB-408075, huC242-DM1
SMILES	[Cantuzumab mertansine]

Storage & Handling

Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.